CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MACULA2 focuses on creating a genetic test for identifying patients with age-related macular degeneration (AMD), a leading cause of blindness. This test aims to improve patient stratification, enabling more effective treatment options and enhancing drug development for AMD therapies.
In MACULA2 we aim to develop a genetic diagnostic test for complement activation that will allow proper stratification of patients with age-related macular degeneration (AMD). AMD is an inflammatory disease, the #1 cause of blindness in the world, with 196 million patients estimated for 2020.
Such a test does not currently exist, strongly hampering drug development and patient treatment.
Poor patient stratification contributes to high failure rates in trials for AMD.
Local and systemic inflammat…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
